爱游戏平台注册登录
check quantity

IVISbrite Yersinia enterocolitic Xen24 Bioluminescent Bacterial Strain

IVISbrite Yersinia enterocolitica Xen24 bioluminescent bacteria was derived from the 91A1854 clinical isolate. For in vitro or in vivo imaging applications, IVISbrite Y. enterocolitica-Xen24 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.

For research use only. Not for use in diagnostic procedures.

貨號 119232
Request Technical Support

請輸入有效數量

請登錄以添加收藏夾。

購物車為空

詳細信息

Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. Our bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers.

  • Engineered Bacterium: Yersinia enterocolitica - Xen24
  • Parental Strain: 91A1854 clinical isolate
  • In Vitro/Ex Vivo: Growth profiles
  • In Vivo: Not tested

Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro:

  • Rapid and readily amenable to high throughput screening, e.g., 96 or 384-well format
  • Sensitivity - subtle changes in cellular viability are rapidly detected
  • Inexpensive - no additional substrates needed for bacterial assays

Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo:

  • Rapid identification of lead drug candidates
  • Real-time efficacy data
  • May help to decrease drug failure by allowing disease relapse to be monitored in the same animal

規格

革蘭氏陽性革蘭氏陰性 Gram negative
熒光素酶分類 Bacterial luciferase
光學成像分類 Bioluminescence Imaging
產品品牌名稱 IVISbrite
運輸條件 環境
治療領域 Infectious Diseases
產品尺寸 1 agar plate
資源
  • 所有

Ebook

了解更多請點擊下載小動物活體成像解決方案

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...

PDF 4 MB

產品手冊

In Vivo Imaging Reagents

Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...

PDF 1 MB

指南

IVISense™ Fluorescent Probe Selector Guide for Oncology Research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.

This s ...

PDF 4 MB

白皮書

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...

PDF 547 KB
Baidu
map